MARK2 Enzyme Promotes Stem Cell Characteristics and Drug Resistance in Liver Cancer
Study identifies that MARK2 promotes stem cell characteristics and drug resistance in hepatocellular carcinoma through Wnt and PI3K/AKT signaling.
Study identifies that MARK2 promotes stem cell characteristics and drug resistance in hepatocellular carcinoma through Wnt and PI3K/AKT signaling.
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.